The emergence of epidemic multiple-drug-resistant strains of Mycobacterium tuberculosis in conjunction with the ending of the downward trend of reported cases of tuberculosis in the United States represents a major public health problem. Implicit in this increased prevalence of tuberculosis is the demand for more rapid and reliable laboratory methods to diagnose M. tuberculosis infections. The introduction of the BACTEC 460 system (Becton Dickinson Diagnostic Instruments, Sparks, Md.) and, more recently, the biphasic SeptiChek AFB System (Roche Diagnostics Systems, Nutley, N.J.) have made major improvements in mycobacterial cultures by providing more rapid detection and better recovery of mycobacteria (10, 11) . DNA probes have also significantly decreased the length of time required for the identification of M. tuberculosis and other mycobacterial species. Several studies have evaluated nucleic acid probes for their ability to identify the M. tuberculosis complex and Mycobacterium avium complex (MAC) directly from BACTEC broth cultures in attempts to further decrease turnaround time. Although identification by nucleic acid probes of MAC directly from BACTEC broth cultures is highly sensitive and specific, several studies have reported lowered sensitivity with M. tuberculosis complex probes (5, 7, 13) . Thus, days to weeks may still be required for sufficient growth for identification.
Because of the obvious demand for a reliable and rapid means of diagnosing tuberculosis for public health and therapeutic reasons, we recently developed and evaluated a PCR assay for its ability to directly detect M. tuberculosis in respiratory specimens (9) ; this assay was also easily incorporated into a clinical laboratory routine. Although our assay had an overall sensitivity and specificity of 87.2 and 97.7%, respectively, at least 16% of specimens contained interfering substances which contributed to lowered sensitivity. Inhibition of PCR by interfering substances in clinical specimens has been reported by several investigators (2, 18, 20) ; the elimination of inhibitory factors remains a challenge in the use and acceptance of PCR assays in the clinical diagnostic setting.
In light of the inherent problems with the use of PCR to directly detect M. tuberculosis in clinical specimens, we evaluated the ability of our PCR assay to detect M. tuberculosis directly in BACTEC 12B broth cultures. We approached this study in two phases: (i) to determine the ability of PCR to detect M. tuberculosis directly in BACTEC 12B vials and (ii) to assess the impact of the PCR assay on the length of time required to report findings of M. tuberculosis in culture.
MATERUILS AND METHODS
Culture protocol. All clinical specimens submitted for routine mycobacteriological smear and culture were processed by standard procedures. In brief, contaminated specimens were digested with 2% NaOH. Following concentration by centrifugation, sediments were resuspended in 3 to 5 ml of phosphate-buffered saline. Smears were prepared, stained with auramine 0, and examined for acid-fast bacilli (AFB) by fluorescence microscopy. During the first phase of our study, a 0.5-ml aliquot of 12B broth was removed when the GI was greater than or equal to 10 and then stored at 4°C until assayed by PCR. On the basis of results from the first phase of our study, the PCR assay was then incorporated into the laboratory routine. Laboratory routine practices were not changed; specimens were processed 7 days/week, and BACTEC 12B bottles were run twice weekly for the first 2 weeks and weekly thereafter for 4 weeks. However, once a 12B vial attained a GI of -10, a 0.5-ml aliquot was removed and stored at 4°C until subsequently assayed by PCR. PCR assays were performed twice weekly. The vial was then handled as previously described by monitoring daily until the GI achieved a value of -100, at which time the presence of AFB was confirmed by staining. Similarly, cultures growing AFB were handled in a routine manner (iii) DNA amplification and product detection. Reaction conditions and product detection were as previously described (9) . In brief, 10 (9) . Similarly, all previously described practices to minimize false-positive results were employed.
Reaction mixtures were then subjected to 40 cycles of amplification. Polyacrylamide gels (8%) were stained with ethidium bromide, and products were then visualized with UV light. The presence of the 123-bp IS6110 product and/or the 10  22  14  209  21  31  13  26  18  406  22  27  10  22  14  371  23  No growth  15  32  16  13  24  20  10  22  13  575  25  No growth  14  30  14  21  26  29  22  30  23  109  27  26  14  26  18  278  28  31  17  17  17  242  29  No growth  38  61  19  144  30  21  17  29  16  15  31  No growth   26  41  20  570  32  60  25  41  21  18  33  40  24  40  20  28  34  No growth  38  61  19  38  35  28  10  22  14  118  36  21  10  26  13  70 and not from broth. Moreover, the average time to detection of M. tuberculosis by the BACTEC system was 13 days, compared with 27 days with solid media; the range for the BACTEC was 4 to 38 days, while the range for solid media was 11 to 60 days. DISCUSSION Despite promising results of numerous published reports, the introduction of PCR into the routine clinical laboratory for the direct detection of M. tuberculosis in clinical specimens has been hampered for a variety of reasons. Problems of contamination, expense, and lack of sensitivity and/or specificity have been reported (2, 3, 6, 9, 14, 17, 18, 20, 21) ; as previously mentioned, clinical specimens can often contain substances which interfere with PCR. In addition, acceptance of PCR into the clinical laboratory setting is further impeded by complex procedures required for amplification, such as cumbersome sample preparation methods.
On the basis an overall sensitivity and specificity of 100 and 99.7%, respectively, PCR proved to be a useful and rapid means for the detection and identification of M. tuberculosis in 12B broth cultures. Of particular interest was the one BACTEC 12B vial which was PCR positive for M. tuberculosis but was culture positive for MAC only; the U culture also yielded MAC. Because of these discrepant results, another aliquot from the 12B vial was assayed by PCR and was again positive for M. tuberculosis sequences. The original and subsequent subcultures of the BACTEC 12B vial showed growth of MAC only, despite careful examination of growth; subsequent hybridization with the M. tuberculosis probe of all subcultures and reprobing of the original subculture were negative. This specimen was obtained from a human immunodeficiency virusinfected patient who was admitted with fever and pulmonary infiltrates; the patient was anergic, and his purified protein derivative status was unknown. During his hospital admission, eight sputum specimens were submitted for mycobacterial culture; of these, four yielded growth of MAC. Since these specimens were submitted during the first phase of our study, only the last specimen submitted for mycobacterial culture was analyzed by PCR. MAC was also recovered from four of four blood specimens. Unfortunately, no further specimens were obtained since the patient died within days of the last specimen submission and no autopsy was performed. Although considered a false positive in our analysis, we feel that the PCR result cannot be totally ruled out as a possible true positive.
Cormican et al. (4) Although PCR may or may not offer significant advantages for the clinical management of patients, PCR may have significant potential to streamline mycobacteriology laboratory practice. The impact of the PCR assay for our laboratory was significant in that the time to identification of M. tuberculosis was halved compared with that obtained by performing nucleic acid probes weekly on growth from the subculture of BACTEC 12B vials. Since many laboratories centrifuge and then probe an aliquot from 12B vials once the GI is in the range of 500 to 999, the impact of the PCR assay in regard to the time to identification of M. tuberculosis for these laboratories may not be as great. Studies are presently under way to determine the shortest incubation of 12B vials required prior to assay by PCR, such that a regular schedule for assay by PCR which easily incorporates into a laboratory's routine yet is sensitive and specific may be established. If M. tuberculosis can subsequently be detected in 12B vials by PCR assay after a minimal period of incubation such that vials are assayed at GIs of .10, all laboratories may realize a significant decrease in the time to identification.
Although larger studies will be required, on the basis of its exquisite sensitivity and reliable specificity, PCR assay of BACTEC 12B vials may obviate the need to use other methods for identification of M. tuberculosis such as a nucleic acid probe for M. tuberculosis complex. Moreover, if amplification-based methods used in conjunction with either hybridization to species-specific probes (1, 8) , sequencing of the amplicon (16), or restriction enzyme analysis of product for subsequent identification to the species level (15, 19) prove sensitive and specific in detecting and identifying all mycobacteria, greater advantages in terms of further decreasing turnaround times, costs, and streamlining of laboratory practices may be realized. Regardless, it should be noted that the more frequently that PCR is performed, the greater its impact on the time to identification of M. tuberculosis will be. Another advantage of using PCR to identify M. tuberculosis in BACTEC 12B broth, which became apparent during our evaluation, was the ability to begin corresponding primary drug susceptibility testing by the BACTEC system earlier than can be done when routine laboratory practices are used. In conclusion, PCR appears to be an easy and reliable means to detect and identify M. tuberculosis in 12B BACTEC broth cultures, on the basis of our findings from this large study.
